cp wire

CP Wire Articles

FDA Accepts Pfizer Submissions for Review of Treatment for Rare Amyloid Related Heart Disease
  • The tafamidis meglumine form (20 mg capsule) has been granted Priority Review

  • Tafamidis was granted Orphan Drug Designation for ATTR-CM in both the EU and US in 2012

... read more

Mon, 01/14/19 - 10:09 am
Release: Vascular Therapies Appoints John McDermott as Chief Executive Officer
Cresskill, NJ.  Vascular Therapies, a biotechnology company focused on improving outcomes for patients with advanced kidney disease today announced the appointment of John... read more
Thu, 01/10/19 - 03:22 pm
Lundbeck Partners with AI Driven Numerate to Tackle Central Nervous System Disorders

Numerate, Inc. announced on 1/7/19 a multi-target research collaboration with Lundbeck Pharmaceutical to identify clinical candidates for the treatment of disorders in the central nervous system,... read more

Mon, 01/7/19 - 10:05 am
Atlantic Therapeutics Raises $32 Million in Series B Financing After FDA Approves is Device to Treat Incontinence

Atlantic Therapeutics announced on 1/7/19 that it has closed €28 million in Series B funding to continue its rapid growth trajectory.
Having recently gained FDA clearance for its INNOVO® ... read more

Mon, 01/7/19 - 09:48 am
Ribon Therapeutics Raises $65 Million to Advance Novel Cancer Pipeline

Ribon Therapeutics, a biotechnology company developing first-in-class therapeutics targeting novel enzyme families activated under cellular stress conditions announced on 1/4/19 the closing of a $... read more

Fri, 01/4/19 - 09:13 am

Pages